Delivery Order SPE2DR25D3005-SPE2DR26FP7WS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $1,605.44 and an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ryanodex 250 mg vials valued at $9,632.64. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $6,421.76 and a firm fixed price contract type. The award, which has no set-aside designation, is scheduled for completion by October 7, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a discrete purchase under the broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $9,632.64 delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials under a firm fixed price contract. The award was announced on September 2, 2025, with an ultimate completion date of September 23, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,632.64 to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials, with an ultimate completion date of June 11, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $9,606.42 to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials, with performance to be completed by December 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as...
- The Defense Logistics Agency awarded a $1,605.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ryanodex 250mg vials with a firm fixed price ceiling value of $57,795.84 and an ultimate completion date of August 18, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an...
- The Defense Logistics Agency awarded a $3,108.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 mg vials of Ryanodex, a pharmaceutical product used in acute care settings. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 10, 2025. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's established infrastructure as a major pharmaceutical...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials on May 30, 2025, with completion scheduled for June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ryanodex is a brand-name medication indicated for the treatment of malignant hyperthermia, a rare but serious pharmacogenetic disorder that can...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7WSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,108.56 to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials on December 9, 2025. This competitively awarded, firm fixed-price contract has a completion date of December 31, 2025 and involves no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ryanodex is a rapid-onset medication used in clinical settings, and this delivery order represents a specific fulfillment under the contractor's existing federal pharmaceutical supply agreements. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive portfolio of delivery orders with the Defense Logistics Agency demonstrates its capability to meet diverse federal medical supply requirements through open competition and firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/8/25 |